iSpecimen Stock (ISPC): Why The Price Went Up Today

By Amit Chowdhry ● Jan 13, 2022
  • The stock price of iSpecimen Inc (NASDAQ: ISPC) increased by over 4% during intraday trading today. This is why it happened.

The stock price of iSpecimen Inc (NASDAQ: ISPC) – an online marketplace for human biospecimens – increased by over 4% during intraday trading today. Investors are responding positively to iSpecimen announcing the expansion of its supplier capabilities with the addition of a reference lab in New York to support commercial and government customers focused on COVID-19 research, including analyzing the Omicron and Delta variants.

The reference lab — a recent addition to the iSpecimen supplier network— has the capacity to sequence hundreds of COVID-19 positive swabs per week, providing data that is crucial in the fight against the virus. This lab is sequencing the most recent swabs to identify new variants of COVID-19 as the virus continues to progress globally.

For researchers looking to validate their own variant identification assays, iSpecimen is able to obtain sequenced and unsequenced COVID-19 positive and negative swabs in a variety of media types.

KEY QUOTES:

“The sequencing of nasal swabs is necessary to determine which variant a patient has tested positive for and provides variant-positive specimens for research. Through our relationship with this reference lab, we are able to quickly and efficiently support both commercial and government researchers working day and night to battle COVID-19.”

— iSpecimen Founder and CEO, Christopher Ianelli, MD, Ph.D.

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.